June 16, 2026 - 01:49

Nvidia CEO Jensen Huang has made a bold call, suggesting that Marvell Technology is on track to become the next trillion-dollar company. Speaking at a recent investor event, Huang highlighted Marvell's critical role in the custom chip and data infrastructure market, positioning it as a key beneficiary of the artificial intelligence boom. Currently valued at roughly $250 billion, Marvell would need to nearly quadruple its market capitalization to hit the trillion-dollar mark.
The road to that valuation, however, is steep and uncertain. Marvell has already seen its stock surge over the past year, driven by demand for its custom ASICs and networking solutions used in AI data centers. Huang's endorsement adds fuel to the fire, but analysts caution that reaching a trillion-dollar valuation would require sustained revenue growth and a massive expansion of its addressable market. Marvell would need to consistently deliver earnings beats and capture a larger share of the AI semiconductor pie, which is currently dominated by Nvidia itself.
Timing is the big question. If the AI infrastructure buildout continues at its current pace, Marvell could see its revenue double or triple within three to five years. But a trillion-dollar valuation implies a price-to-earnings multiple that would far exceed historical norms, even for high-growth tech stocks. Market volatility, competition from Broadcom and other custom chip designers, and potential shifts in AI spending could slow the climb. For now, Huang's prediction has investors watching closely, but the journey from $250 billion to $1 trillion is a marathon, not a sprint.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...